Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: A population-based cohort study

Breast Cancer Research

Volumn 11, Issue 4, 2009, Pages

  Kalager, Mette ^a   Haldorsen, Tor ^a   Bretthauer, Michael ^a   Hoff, Geir ^a   Thoresen, Steinar O ^a   Adami, Hans Olov ^a,b,c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NORWAY; POPULATION BASED CASE CONTROL STUDY; SURVIVAL RATE; BREAST TUMOR; CANCER CENTER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; HEALTH CARE QUALITY; KAPLAN MEIER METHOD; MANDATORY REPORTING; MASS SCREENING; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PROPORTIONAL HAZARDS MODEL; PUBLIC HEALTH; RADIOGRAPHY; REGISTER; STATISTICS;

AGED; BREAST NEOPLASMS; CANCER CARE FACILITIES; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MAMMOGRAPHY; MANDATORY REPORTING; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NORWAY; PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SURVIVAL RATE;

EID: 70449575388     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2331     Document Type: Article

References (26)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-2150. 10.1200/JCO.2005.05.2308, 16682732.
2. Cancer Trends Progress Report-2007 update. , http://progressreport.cancer.gov/popups/d2b.html
3. Early Breast Cancer Trialists' Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. 10.1016/S0140-6736(05)66544-0, 15894097, Early Breast Cancer Trialists' Collaborative Group.
4. Early Breast Cancer Trialists' Collaborative Group Multi-agent chemotherapy for early breast cancer. Cochrane Database Syst Rev 2002, (1):CD000487. Early Breast Cancer Trialists' Collaborative Group.
5. Vervoort MM, Draisma G, Fracheboud J, Poll-Franse LV, de Koning HJ. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 2004, 91:242-247.
6. Nystrom L, Andersson L, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002, 359:909-919. 10.1016/S0140-6736(02)08020-0, 11918907.
7. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, Tanque UB, Blichert-Toft M, Rank F, Mouridsen H, Lynge E. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005, 330:220. 546064, 15649904, 10.1136/bmj.38313.639236.82.
8. Berry DA, Corin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353:1784-1792. 10.1056/NEJMoa050518, 16251534.
9. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003, 361:1405-1410. 10.1016/S0140-6736(03)13143-1, 12727392.
10. Consumer Report 4/2002 (Norwegian). , http://forbrukerportalen.no/filearchive/4_2002_s_1_48.pdf
11. AJCC 2002 Cancer Staging Handbook. 2002, New York: Springer Verlag, Sixth, AJCC 2002.
12. Norwegian Ministry of Social Affairs. Norwegian Official Report (NOU) No 7 Mammography screening in Norway [Norwegian]. 1987, Norwegian Ministry of Social Affairs. Norwegian Official Report (NOU) No 7.
13. Erzaas A. Quality Assurance Manual of the Norwegian Breast Cancer Screening Program [Norwegian]. 1996, The Cancer Registry of Norway, Oslo, Norway., http://
14. Perry N, Broeders M, de Wolf C. European guidelines for quality assurance in breast cancer screening and diagnosis. 1996, Office for official publications of the European Communities (ISBN 92-827-7430-9); Luxembourg, 2.
15. Wang H, Kåresen R, Hervik A, Thoresen S. Mammography screening in Norway: results from the first screening round in four counties and cost effectiveness of a modeled nationwide screening. Cancer Causes Control 2001, 12:39-45. 10.1023/A:1008999403069, 11227924.
16. Hofvind S, Thoresen S, Langmark F. A pilot study of mammography activity at two private institutions in Norway [Norwegian] Report 1-2006. 2006, The Cancer Registry of Norway, Oslo, Norway.
17. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985, 312:1604-1608.
18. Stockton D, Davies T, Day N, McCann J. Retrospective study for reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment?. BMJ 1997, 314:472-475. 2126011, 9056796.
19. Nab HW, Hop WC, Crommelin MA, Kluck HM. Changes in long term prognosis for breast cancer in a Dutch cancer registry. BMJ 1994, 309:83-86. 2540542, 8038671.
20. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002, 347:1227-1232. 10.1056/NEJMoa020989, 12393819.
21. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241. 10.1056/NEJMoa022152, 12393820.
22. Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553. 10.1056/NEJMoa012782, 12904519.
23. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ 1996, 312:145-148. 2349835, 8563532.
24. Kingsmore D, Ssemwogerere A, Hole D, Gillis C. Specialisation and breast cancer survival in the screening era. Br J Cancer 2003, 88:1708-1712. 10.1038/sj.bjc.6600949, 12771985.
25. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995, 345:1265-1270. 10.1016/S0140-6736(95)90924-9, 7746056.
26. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000, 321:665-669. 27479, 10987769, 10.1136/bmj.321.7262.665.